Literature DB >> 16091994

The effect of formulation variables and breathing patterns on the site of nasal deposition in an anatomically correct model.

Yang Guo1, Beth Laube, Richard Dalby.   

Abstract

PURPOSE: This study was conducted to evaluate the effect of formulation variables and breathing patterns on aerosol distribution in the nasal cavity.
METHODS: Placebo nasal spray formulations containing 0.25% w/v Avicel CL611 (viscosity = 4 cP) and 2% w/v methylcellulose (MC; viscosity = 18.2 cP) were radiolabeled with (99m)Technicium. Following spraying into a silicone nose model, through which air was drawn at one of three constant rates (0, 10, and 20 L/min) or one of two breathing profiles (representing fast and slow inhalations), aerosol deposition in the model was quantified by gamma scintigraphy. Regional deposition was expressed as horizontal[inner, middle (h), outer] and vertical distribution [upper, middle (v), lower] in the nose model.
RESULTS: Compared to 2% MC, Avicel CL611 significantly increased aerosol deposition in the middle (h) region of the nasal cavity under all breathing conditions, and in the inner region at 0 and 20 L/min and with a slow inhalation. The different breathing rates showed no effect on deposition of 2% MC. However, 10 L/min significantly increased the upper deposition of Avicel compared to 0 and 20 L/min.
CONCLUSIONS: Nasal sprays with a low viscosity provided greater surface coverage of the nasal mucosa than higher viscosity formulations. Changes in breathing profiles did not affect aerosol deposition in this nose model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091994     DOI: 10.1007/s11095-005-7391-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  6 in total

1.  Commentary on the FDA draft guidance for bioequivalence studies for nasal aerosols and nasal sprays for local action: an industry view.

Authors:  L I Harrison
Journal:  J Clin Pharmacol       Date:  2000-07       Impact factor: 3.126

2.  Characterization of nasal spray pumps and deposition pattern in a replica of the human nasal airway.

Authors:  Y S Cheng; T D Holmes; J Gao; R A Guilmette; S Li; Y Surakitbanharn; C Rowlings
Journal:  J Aerosol Med       Date:  2001

3.  Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition.

Authors:  Julie D Suman; Beth L Laube; Ta-Chun Lin; Guillaume Brouet; Richard Dalby
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

Review 4.  Permeability issues in nasal drug delivery.

Authors:  Priyanka Arora; Shringi Sharma; Sanjay Garg
Journal:  Drug Discov Today       Date:  2002-09-15       Impact factor: 7.851

5.  Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin.

Authors:  A S Harris; E Svensson; Z G Wagner; S Lethagen; I M Nilsson
Journal:  J Pharm Sci       Date:  1988-05       Impact factor: 3.534

6.  The distribution of an intranasal insulin formulation in healthy volunteers: effect of different administration techniques.

Authors:  S P Newman; K P Steed; J G Hardy; I R Wilding; G Hooper; R A Sparrow
Journal:  J Pharm Pharmacol       Date:  1994-08       Impact factor: 3.765

  6 in total
  15 in total

1.  Assessment of nasal spray deposition pattern in a silicone human nose model using a color-based method.

Authors:  Vipra Kundoor; Richard N Dalby
Journal:  Pharm Res       Date:  2009-11-10       Impact factor: 4.200

2.  Effect of formulation- and administration-related variables on deposition pattern of nasal spray pumps evaluated using a nasal cast.

Authors:  Vipra Kundoor; Richard N Dalby
Journal:  Pharm Res       Date:  2011-04-16       Impact factor: 4.200

3.  Visualization and Quantification of Nasal and Olfactory Deposition in a Sectional Adult Nasal Airway Cast.

Authors:  Jinxiang Xi; Jiayao Eddie Yuan; Yu Zhang; Dannielle Nevorski; Zhaoxuan Wang; Yue Zhou
Journal:  Pharm Res       Date:  2016-03-04       Impact factor: 4.200

Review 4.  A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research.

Authors:  Marilena M DeMayo; Yun Ju C Song; Ian B Hickie; Adam J Guastella
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

5.  In Vitro Assessment of Spray Deposition Patterns in a Pediatric (12 Year-Old) Nasal Cavity Model.

Authors:  Namita Sawant; Maureen D Donovan
Journal:  Pharm Res       Date:  2018-03-26       Impact factor: 4.200

6.  Development of in vitro models to demonstrate the ability of PecSys®, an in situ nasal gelling technology, to reduce nasal run-off and drip.

Authors:  Jonathan Castile; Yu-Hui Cheng; Ben Simmons; Michael Perelman; Alan Smith; Peter Watts
Journal:  Drug Dev Ind Pharm       Date:  2012-07-17       Impact factor: 3.225

7.  Numerical evaluation of spray position for improved nasal drug delivery.

Authors:  Saikat Basu; Landon T Holbrook; Kathryn Kudlaty; Olulade Fasanmade; Jihong Wu; Alyssa Burke; Benjamin W Langworthy; Zainab Farzal; Mohammed Mamdani; William D Bennett; Jason P Fine; Brent A Senior; Adam M Zanation; Charles S Ebert; Adam J Kimple; Brian D Thorp; Dennis O Frank-Ito; Guilherme J M Garcia; Julia S Kimbell
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

8.  Liquid Film Translocation Significantly Enhances Nasal Spray Delivery to Olfactory Region: A Numerical Simulation Study.

Authors:  Xiuhua April Si; Muhammad Sami; Jinxiang Xi
Journal:  Pharmaceutics       Date:  2021-06-18       Impact factor: 6.321

9.  Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review.

Authors:  Per Gisle Djupesland
Journal:  Drug Deliv Transl Res       Date:  2012-10-18       Impact factor: 4.617

10.  Numerical optimization of targeted delivery of charged nanoparticles to the ostiomeatal complex for treatment of rhinosinusitis.

Authors:  Jinxiang Xi; Jiayao Eddie Yuan; Xiuhua April Si; James Hasbany
Journal:  Int J Nanomedicine       Date:  2015-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.